Evidence map›Paper›PMID 27654291›Full record

ArticleJournal of virology2016

Hepacivirus NS3/4A Proteases Interfere with MAVS Signaling in both Their Cognate Animal Hosts and Humans: Implications for Zoonotic Transmission.

Anggakusuma, Richard J P Brown, Dominic H Banda, Daniel Todt, Gabrielle Vieyres, Eike Steinmann, Thomas Pietschmann

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Identification of claudin-3 as an entry factor for rat hepacivirus.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Porcine Sapelovirus 3CFrontiers in cellular and infection microbiology · 2022
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Animal Models of Hepatitis C Virus Infection.Cold Spring Harbor perspectives in medicine · 2020
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

AnggakusumaInstitute for Experimental Virology, Centre for Experimental and Clinical Infection Research, TWINCORE, Hanover, Germany.
Richard J P BrownInstitute for Experimental Virology, Centre for Experimental and Clinical Infection Research, TWINCORE, Hanover, Germany.
Dominic H BandaInstitute for Experimental Virology, Centre for Experimental and Clinical Infection Research, TWINCORE, Hanover, Germany.
Daniel TodtInstitute for Experimental Virology, Centre for Experimental and Clinical Infection Research, TWINCORE, Hanover, Germany.
Gabrielle VieyresInstitute for Experimental Virology, Centre for Experimental and Clinical Infection Research, TWINCORE, Hanover, Germany.
Eike SteinmannInstitute for Experimental Virology, Centre for Experimental and Clinical Infection Research, TWINCORE, Hanover, Germany.
Thomas PietschmannInstitute for Experimental Virology, Centre for Experimental and Clinical Infection Research, TWINCORE, Hanover, Germany thomas.pietschmann@twincore.de.
Center for Experimental and Clinical Infection Research · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multiple novel members of the genus Hepacivirus have recently been discovered in diverse mammalian species. However, to date, their replication mechanisms and zoonotic potential have not been explored in detail. The NS3/4A serine protease of hepatitis C virus (HCV) is critical for cleavage of the viral polyprotein. It also cleaves the cellular innate immune adaptor MAVS, thus decreasing interferon (IFN) production and contributing to HCV persistence in the human host. To investigate the conservation of fundamental aspects of the hepaciviral life cycle, we explored if MAVS cleavage and suppression of innate immune signaling represent a common mechanism employed across different clades of the genus Hepacivirus to enhance viral replication. To estimate the zoonotic potential of these nonhuman hepaciviruses, we assessed if their NS3/4A proteases were capable of cleaving human MAVS. NS3/4A proteases of viruses infecting colobus monkeys, rodents, horses, and cows cleaved the MAVS proteins of their cognate hosts and interfered with the ability of MAVS to induce the IFN-β promoter. All NS3/4A proteases from nonhuman viruses readily cleaved human MAVS. Thus, NS3/4A-dependent cleavage of MAVS is a conserved replication strategy across multiple clades within the genus Hepacivirus Human MAVS is susceptible to cleavage by these nonhuman viral proteases, indicating that it does not pose a barrier for zoonotic transmission of these viruses to humans. IMPORTANCE: Virus infection is recognized by cellular sensor proteins triggering innate immune signaling and antiviral defenses. While viruses have evolved strategies to thwart these antiviral programs in their cognate host species, these evasion mechanisms are often ineffective in a novel host, thus limiting viral transmission across species. HCV, the best-characterized member of the genus Hepacivirus within the family Flaviviridae, uses its NS3/4A protease to disrupt innate immune signaling by cleaving the cellular adaptor protein MAVS. Recently, a large number of HCV-related viruses have been discovered in various animal species, including wild, livestock, and companion animals. We show that the NS3/4A proteases of these hepaciviruses from different animals and representing various clades of the genus cleave their cognate host MAVS proteins in addition to human MAVS. Therefore, cleavage of MAVS is a common strategy of hepaciviruses, and human MAVS is likely unable to limit replication of these nonhuman viruses upon zoonotic exposure.

Indexed as

Adaptor Proteins, Signal TransducingAmino Acid MotifsAmino Acid SequenceAnimalsConserved SequenceEvolution, MolecularGenetic VariationHepacivirusHepatitis CHost SpecificityHumansImmunity, InnateSerine ProteasesSignal TransductionViral Nonstructural ProteinsVirus ReplicationAdaptor Proteins, Signal TransducingMAVS protein, humanNS3-4A serine protease, Hepatitis C virusSerine ProteasesViral Nonstructural Proteins

Identifiers

PMID27654291
PMCPMC5110154
OpenAlexW2600395401

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.